Predicting diabetes after kidney transplant using microRNA
Part of Hormones & metabolism clinical trials.
This study looks at tiny molecules called microRNAs to predict if new diabetes might develop after a kidney transplant. By measuring these molecules in your blood, researchers hope to catch early signs and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) getting a kidney transplant.
- You did not have diabetes (type 1 or 2) before the transplant.
- You have not had any previous organ transplant.
- You do not have a serious pancreas condition.
- You are willing to take part in all study procedures and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study looks at whether certain tests can help predict or diagnose kidney transplant rejection. If you have had a kidney transplant and are being followed at a main transplant centre in Scotland, you may be able to take part by giving urine samples during your regular check-ups.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study looks at special blood tests to help predict when kidney transplant rejection might happen. If the markers work, they could help doctors catch rejection earlier and adjust treatment sooner.
This study helps doctors predict who may develop complications from diabetes that appears after a kidney transplant. By understanding your individual risk, your care team can better prevent problems and keep your transplanted kidney healthy longer.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.